Hagerman Allison, VP of Product Development, made one open market purchase of Oncolytics Biotech Inc. (ONCY) shares in the last year, totaling $8,298. Her most recent buy occurred on February 12, 2026. This places her in 4,410th position among nearly 5,000 insiders by purchase value, well below the average of $1.46 million across about 3.3 transactions per insider. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Hagerman Allison | VP, Product Development | P | Common Shares | 10000 | $0.83 | 115,059.0000 | 80,020,131 | 9.52% | 0.01% |